vs
科迪华（CTVA）与Raymond James Financial（RJF）财务数据对比。点击上方公司名可切换其他公司
Raymond James Financial的季度营收约是科迪华的1.1倍（$4.2B vs $3.9B），Raymond James Financial净利率更高（13.5% vs -14.1%，领先27.6%），Raymond James Financial同比增速更快（3.5% vs -1.7%），科迪华自由现金流更多（$4.2B vs $-56.0M），过去两年Raymond James Financial的营收复合增速更高（7.1% vs -6.7%）
科迪华是一家美国农业科技企业，主营种子与作物保护产品，涵盖除草剂、杀虫剂、杀菌剂及生物制剂，业务覆盖全球110个国家，总部位于印第安纳州印第安纳波利斯，旗下大部分种子产品以先锋良种国际品牌销售。
雷蒙德詹姆斯金融是美国跨国独立投资银行及金融服务机构，通过旗下子公司为个人、企业及市政主体提供多元金融服务，核心业务覆盖投资与财务规划、投资银行、资产管理等领域，总部位于美国佛罗里达州圣彼得堡。
CTVA vs RJF — 直观对比
营收规模更大
RJF
是对方的1.1倍
$3.9B
营收增速更快
RJF
高出5.2%
-1.7%
净利率更高
RJF
高出27.6%
-14.1%
自由现金流更多
CTVA
多$4.2B
$-56.0M
两年增速更快
RJF
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.9B | $4.2B |
| 净利润 | $-552.0M | $563.0M |
| 毛利率 | 42.4% | — |
| 营业利润率 | -13.6% | — |
| 净利率 | -14.1% | 13.5% |
| 营收同比 | -1.7% | 3.5% |
| 净利润同比 | -1246.3% | -6.2% |
| 每股收益（稀释后） | $-0.80 | $2.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTVARJF
| Q4 25 | $3.9B | $4.2B | ||
| Q3 25 | $2.6B | $4.2B | ||
| Q2 25 | $6.5B | $3.8B | ||
| Q1 25 | $4.4B | $3.8B | ||
| Q4 24 | $4.0B | $4.0B | ||
| Q3 24 | $2.3B | $4.0B | ||
| Q2 24 | $6.1B | $3.8B | ||
| Q1 24 | $4.5B | $3.6B |
净利润CTVARJF
| Q4 25 | $-552.0M | $563.0M | ||
| Q3 25 | $-320.0M | $604.0M | ||
| Q2 25 | $1.3B | $436.0M | ||
| Q1 25 | $652.0M | $495.0M | ||
| Q4 24 | $-41.0M | $600.0M | ||
| Q3 24 | $-524.0M | $602.0M | ||
| Q2 24 | $1.1B | $492.0M | ||
| Q1 24 | $419.0M | $476.0M |
毛利率CTVARJF
| Q4 25 | 42.4% | — | ||
| Q3 25 | 37.2% | — | ||
| Q2 25 | 54.6% | — | ||
| Q1 25 | 47.0% | — | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 32.7% | — | ||
| Q2 24 | 52.3% | — | ||
| Q1 24 | 43.2% | — |
营业利润率CTVARJF
| Q4 25 | -13.6% | — | ||
| Q3 25 | -14.1% | — | ||
| Q2 25 | 27.9% | 14.7% | ||
| Q1 25 | 17.7% | 17.5% | ||
| Q4 24 | 2.2% | 18.6% | ||
| Q3 24 | -27.2% | — | ||
| Q2 24 | 21.9% | 17.1% | ||
| Q1 24 | 10.7% | 16.7% |
净利率CTVARJF
| Q4 25 | -14.1% | 13.5% | ||
| Q3 25 | -12.2% | 14.4% | ||
| Q2 25 | 20.4% | 11.3% | ||
| Q1 25 | 14.8% | 12.9% | ||
| Q4 24 | -1.0% | 14.9% | ||
| Q3 24 | -22.5% | 15.0% | ||
| Q2 24 | 17.2% | 13.1% | ||
| Q1 24 | 9.3% | 13.1% |
每股收益（稀释后）CTVARJF
| Q4 25 | $-0.80 | $2.79 | ||
| Q3 25 | $-0.47 | $2.96 | ||
| Q2 25 | $1.92 | $2.12 | ||
| Q1 25 | $0.95 | $2.36 | ||
| Q4 24 | $-0.05 | $2.86 | ||
| Q3 24 | $-0.76 | $2.85 | ||
| Q2 24 | $1.51 | $2.31 | ||
| Q1 24 | $0.60 | $2.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $9.9B |
| 总债务越低越好 | $1.7B | — |
| 股东权益账面价值 | $24.1B | $12.6B |
| 总资产 | $42.8B | $88.8B |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资CTVARJF
| Q4 25 | $4.5B | $9.9B | ||
| Q3 25 | $2.6B | $11.4B | ||
| Q2 25 | $2.1B | $9.2B | ||
| Q1 25 | $2.0B | $9.7B | ||
| Q4 24 | $3.2B | $10.0B | ||
| Q3 24 | $2.5B | $11.0B | ||
| Q2 24 | $2.0B | $9.1B | ||
| Q1 24 | $1.7B | $10.0B |
总债务CTVARJF
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | $2.5B | — |
股东权益CTVARJF
| Q4 25 | $24.1B | $12.6B | ||
| Q3 25 | $25.2B | $12.5B | ||
| Q2 25 | $25.9B | $12.3B | ||
| Q1 25 | $24.3B | $12.2B | ||
| Q4 24 | $23.8B | $11.9B | ||
| Q3 24 | $24.7B | $11.7B | ||
| Q2 24 | $25.2B | $11.2B | ||
| Q1 24 | $24.8B | $11.0B |
总资产CTVARJF
| Q4 25 | $42.8B | $88.8B | ||
| Q3 25 | $42.2B | $88.2B | ||
| Q2 25 | $41.8B | $84.8B | ||
| Q1 25 | $42.1B | $83.1B | ||
| Q4 24 | $40.8B | $82.3B | ||
| Q3 24 | $41.9B | $83.0B | ||
| Q2 24 | $41.5B | $80.6B | ||
| Q1 24 | $43.6B | $81.2B |
负债/权益比CTVARJF
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.07× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | 0.08× | — | ||
| Q2 24 | 0.10× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.4B | $-10.0M |
| 自由现金流经营现金流 - 资本支出 | $4.2B | $-56.0M |
| 自由现金流率自由现金流/营收 | 106.2% | -1.3% |
| 资本支出强度资本支出/营收 | 5.7% | 1.1% |
| 现金转化率经营现金流/净利润 | — | -0.02× |
| 过去12个月自由现金流最近4个季度 | $2.8B | $1.4B |
8季度趋势，按日历期对齐
经营现金流CTVARJF
| Q4 25 | $4.4B | $-10.0M | ||
| Q3 25 | $193.0M | $796.0M | ||
| Q2 25 | $947.0M | $691.0M | ||
| Q1 25 | $-2.1B | $117.0M | ||
| Q4 24 | $4.2B | $830.0M | ||
| Q3 24 | $130.0M | $510.0M | ||
| Q2 24 | $451.0M | $711.0M | ||
| Q1 24 | $-2.6B | $391.0M |
自由现金流CTVARJF
| Q4 25 | $4.2B | $-56.0M | ||
| Q3 25 | $36.0M | $752.0M | ||
| Q2 25 | $829.0M | $634.0M | ||
| Q1 25 | $-2.2B | $71.0M | ||
| Q4 24 | $4.0B | $789.0M | ||
| Q3 24 | $-24.0M | $460.0M | ||
| Q2 24 | $337.0M | $655.0M | ||
| Q1 24 | $-2.8B | $342.0M |
自由现金流率CTVARJF
| Q4 25 | 106.2% | -1.3% | ||
| Q3 25 | 1.4% | 17.9% | ||
| Q2 25 | 12.8% | 16.5% | ||
| Q1 25 | -49.9% | 1.8% | ||
| Q4 24 | 100.4% | 19.6% | ||
| Q3 24 | -1.0% | 11.5% | ||
| Q2 24 | 5.5% | 17.4% | ||
| Q1 24 | -61.4% | 9.4% |
资本支出强度CTVARJF
| Q4 25 | 5.7% | 1.1% | ||
| Q3 25 | 6.0% | 1.1% | ||
| Q2 25 | 1.8% | 1.5% | ||
| Q1 25 | 2.1% | 1.2% | ||
| Q4 24 | 4.6% | 1.0% | ||
| Q3 24 | 6.6% | 1.2% | ||
| Q2 24 | 1.9% | 1.5% | ||
| Q1 24 | 3.3% | 1.3% |
现金转化率CTVARJF
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | 1.32× | ||
| Q2 25 | 0.72× | 1.58× | ||
| Q1 25 | -3.23× | 0.24× | ||
| Q4 24 | — | 1.38× | ||
| Q3 24 | — | 0.85× | ||
| Q2 24 | 0.43× | 1.45× | ||
| Q1 24 | -6.23× | 0.82× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |
RJF
暂无分部数据
